Biomedical, Therapeutic and Clinical Applications of Bioactive Glasses
| Other Authors: | Kaur, Gurbinder (Materials scientist), ScienceDirect (Online service) |
|---|---|
| Format: | Electronic |
| Language: | English |
| Published: |
San Diego :
Woodhead Publishing,
2018.
|
| Physical Description: |
1 online resource (586 pages). |
| Series: |
Woodhead Publishing series in biomaterials.
|
| Subjects: |
Table of Contents:
- Front Cover; Biomedical, Therapeutic and Clinical Applications of Bioactive Glasses; Copyright; Dedication; Contents; Contributors; Editor's Biography; Foreword; Acknowledgments; Part I Fundamentals of Bioactive Glasses; Chapter 1 Bioactive Glass Containing Coatings by Electrophoretic Deposition: Development and Applications; 1.1 Introduction; 1.2 Electrophoretic Deposition; 1.3 Bioactive Glass Coatings; 1.4 Polymer/BG Composite Coatings; 1.4.1 PEEK-BG Coatings; 1.4.2 Degradable Polymer-BG Coatings; 1.5 Incorporation of Drugs; 1.6 Characterization of Coatings; 1.7 Conclusions; References.
- Further ReadingChapter 2 Multifunctional Bioactive Glasses and Glass-Ceramics: Beyond 'Traditional' Bioactivity; 2.1 Introduction; 2.2 Drug Release; 2.3 Antibacterial Properties; 2.4 Promotion of Angiogenesis; 2.5 Applications in Contact With Soft Tissues; 2.6 Antioxidant Properties; 2.7 Bone Cancer Treatment; 2.8 Applications for Clinical Imaging and Biolabeling; 2.9 Summary; References; Chapter 3 Synthesis and Characterization of Doped Bioactive Glasses; 3.1 Bioactive Glasses Obtained by Melting at High Temperature-The Beginning; 3.1.1 Overview; 3.1.2 The SiO2-CaO-Na2O System.
- 3.1.2.1 Overview3.1.2.2 Selection of Compositions; 3.1.2.3 Bioactivity of the SiO2-CaO-Na2O System; 3.1.2.3.1 Bioactivity in Terms of HCA Nucleation Time; 3.1.2.3.2 Bioactivity in Terms of Thickness; 3.2 Doping of Glasses of the SiO2-CaO-Na2O System by P2O5 (Lebecq et al., 2007; Lebecq, 2002); 3.2.1 Overview; 3.2.2 Selection of Compositions; 3.2.3 Bioactivity of SiO2-CaO-Na2O-P2O5 System; 3.2.3.1 Bioactivity in Terms of Time of HCA Layer's Nucleation; 3.2.3.2 Bioactivity in Terms of Thickness; 3.2.4 Correlation Between Glass Structure and Bioactivity (Mercier et al., 2011; Pardini, 2007)
- 3.2.5 Development of a Doped Macroporous Bioactive Glass3.3 Mixture Designs Applied to the SiO2-CaO-Na2O System Doped With P2O5 and CaF2; 3.3.1 Selection of Doping; 3.3.2 Mixture Designs (Goupy, 2000); 3.3.3 Results (Duée et al., 2012, 2013); 3.4 Improvement of the Mechanical Properties of Bioactive Glasses by Doping With Nitrogen; 3.4.1 Overview; 3.4.2 Selection of Glasses; 3.4.3 N-Doping of Si-Na-Ca-O Glasses (Bachar et al., 2016); 3.4.3.1 Chemical Analysis; 3.4.3.2 Structural Characterizations by 29Si NMR Spectroscopy; 3.4.4 N-Doping of Si-Ca-Na-O-F System Glasses (Bachar et al., 2013a)
- 3.4.4.1 Chemical Analysis3.4.4.2 Structural Characterizations by 29Si and 19F MAS NMR Spectroscopy (Bachar et al., 2013a); 3.4.5 Physicochemical Properties of Si-Ca-Na-O-N and Si-Ca-Na-O-F-N Glasses (Bachar et al., 2013b); 3.4.6 Mechanical properties Si-Ca-Na-O-N and Si-Ca-Na-O-F-N (Bachar et al., 2013b); 3.4.7 Bioactivity of Si-Ca-Na-O-N and Si-Ca-Na-O-F-N Glasses (Bachar, 2012); 3.5 Sol-Gel Quaternary Bioactive Glasses and Their Silver Doping; 3.5.1 Overview; 3.5.2 Sol-Gel Synthesis Methods for Invert Glasses; 3.5.3 Results (Catteaux, 2015; Catteaux et al., 2013); 3.6 Conclusion.